Besides its direct protumorigenic effects on tumor cells via STAT3/Akt pathways, IL-6 signaling has indirect effects by promoting an immunosuppressive tumor microenvironment, which has been described in a Kras-induced lung cancer mouse model28. This evidence concerns the gene KRAS and lung carcinoma.